French pharma giant Servier to invest €15 million to launch global single-pill platform 'GATINN' in India

French pharma group Servier is expanding in India with a €15 million investment to launch GATINN, a global platform for single pill combinations (SPCs) targeting cardiometabolic and venous diseases. The India-based hub will coordinate research, manufacturing, and exports to international markets, aiming to improve patient adherence by combining multiple drugs into a single daily dose.